AMENDED STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Company

COLLEGIUM PHARMACEUTICAL, INC

Filed

March 18, 2025

Period of Report

March 11, 2025

Accession Number

0001062993-25-005834